BMS 433796 25mg 25mg | Purity Not Available
Adooq Bioscience
BMS 433796 is a ??-secretase inhibitor with A?? lowering activity in a transgenic mouse model of Alzheimer’s disease.
More Information Supplier PageBMS 433796 is a ??-secretase inhibitor with A?? lowering activity in a transgenic mouse model of Alzheimer’s disease.
More Information Supplier PageBMS 433796 is a ??-secretase inhibitor with A?? lowering activity in a transgenic mouse model of Alzheimer’s disease.
More Information Supplier PageBMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBalapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageBalapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageBMS 433796 is a ??-secretase inhibitor with A?? lowering activity in a transgenic mouse model of Alzheimer’s disease.
More Information Supplier PageBay 65-1942 is an ATP-competitive inhibitor that selectively targets IKK?? kinase activity.
More Information Supplier Page